Abstract
Angiogenesis is a process by which new blood vessels are formed from pre-existing ones. It is regulated by the balance between angiogenic factors and angiogenesis inhibitors. Angiogenesis is considered to be essential for the growth of various solid tumors. Therefore, the inhibition of tumor angiogenesis has become a new strategy for the treatment of malignant tumors. This review describes the recent understanding of the mechanism of angiogenesis, the factors involved in angiogenesis, and the anti-angiogenic drugs in current clinical trials.
| Original language | English |
|---|---|
| Pages (from-to) | 147-153 |
| Number of pages | 7 |
| Journal | Biotherapy |
| Volume | 13 |
| Issue number | 2 |
| Publication status | Published - 1999 |
Keywords
- Angiogenesis inhibitor
- Angiogenic factor
- Anti- angiogenic therapy
- Tumor angiogenesis
